Latest Clinical & Research News
Boston area experts recently commented on the digital technologies they’re using in a pilot of a surgical home hospital in bariatric surgery at Brigham and Women’s Hospital.
Read More...
Researchers at Brigham and Women’s Hospital recently published data from an open-label phase 1b/2a trial suggesting induction therapy with low-dose IL-2 is safe for patients with ulcerative colitis and suppresses the disease.
Read More...
Cardiovascular experts from Brigham and Women’s Hospital will present at this year’s Transcatheter Cardiovascular Therapeutics (TCT) Conference on interventional cardiology, held October 23–26 in San Francisco, CA.
Read More...
Using a novel method, Brigham and Women’s Hospital researchers completed the first comparative proteomics study of pathogenesis in calcified carotid arteries and aortic valves (AVs), identifying unique drivers of atherosclerosis versus AV stenosis and implicating extracellular vesicles in both diseases.
Read More...
Immunotherapy drugs that harness a patient’s immune system to fight cancer have become an important treatment for a subset of patients with certain cancers. A team co-led by investigators from Brigham and Women’s Hospital has uncovered new findings about why some patients fail to respond to these drugs. The research suggests new approaches for making the medications more effective. Read More
In October, The New England Journal of Medicine published a case vignette focusing on a 61-year-old man with prostate cancer. Two physicians—Anthony Victor D’Amico, MD, PhD, chief of Genitourinary Radiation Oncology at Dana-Farber Brigham Cancer Center, and Freddie Hamdy, FRCS(Urol.), FMedSci, of the Nuffield Department of Surgical Sciences at the University of Oxford—present evidence on the appropriate clinical care approach. NEJM readers can cast their vote on which direction they would take based on the two essays. Read More
Researchers at Brigham and Women’s Hospital believe an implanted intracranial stimulation system could increase both the strength and duration of tumor treating fields (TTF) delivery.
Read More...
The efficacy of prostate-specific antigen (PSA) screening in reducing prostate cancer (PCa) mortality remains a matter of debate. Nonetheless, some racial and ethnic minority groups—particularly Black and Hispanic men—are less likely to receive prostate cancer screening and treatment. This discrepancy, in turn, may contribute to racial and ethnic disparities in PCa outcomes, including higher mortality rates. Read More
Researchers at Brigham and Women’s Hospital have redefined the nature of soluble Aβ, a key advance pertinent to future drug design for AD.
Read More...
A team at the Brigham’s Lung Center performed a complex, two-step procedure to place endobronchial valves in a 59-year-old woman who had hyperinflation of her lungs due to advanced COPD, combined with an incomplete lobar fissure. Interventional pulmonologist Majid Shafiq, MD, MPH, discusses this challenging case.
Read More...